New Jersey Headlines

Radiofrequency Ablation Devices Market Size Anticipated To Trigger A Revenue Increase To Worth $6.7 Billion By 2026: Grand View Research, Inc.

 Breaking News
  • No posts were found

Radiofrequency Ablation Devices Market Size Anticipated To Trigger A Revenue Increase To Worth $6.7 Billion By 2026: Grand View Research, Inc.

March 26
11:03 2019
Radiofrequency Ablation Devices Market Size Anticipated To Trigger A Revenue Increase To Worth $6.7 Billion By 2026: Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, Increasing preference for minimally invasive surgeries, growing geriatric population, and rise in healthcare spending for better disease treatment are expected to propel the radiofrequency ablation devices market growth.

According to a report,Radiofrequency Ablation Devices Market Size, Share & Trends Analysis Report By Product (Disposable, Capital, Reusable Equipment), By Application, By Region, And Segment Forecasts, 2019 – 2026”, published by Grand View Research, Inc., The global radiofrequency ablation devices market size is anticipated to reach USD 6.7 billion by 2026. It is expected to register a CAGR of 11.6% during the forecast period. Increasing preference for minimally invasive surgeries, growing geriatric population, and rise in healthcare spending for better disease treatment are expected to propel the growth.

Key Takeaways from the report:

  • Disposable equipment held the largest market share in 2018 due to reduced morbidity and mortality and the ability of the equipment to provide treatment in an outpatient setting. For example, Radiopaque RF cannula (Halyard Worldwide, Inc) provides improved visualization under fluoroscopy for accurate positioning, resulting in a targeted treatment

  • Cardiology and cardiac rhythm management is anticipated to be the fastest-growing segment during the forecast period due to disease prevalence, growing awareness, and adoption of minimally invasive operations. In 2012 RFA-Academia launched an initiative to increase awareness in Europe and to teach endoscopists safe and justified application of RFA to reduce the disease burden

  • North America is anticipated to continue leading the radiofrequency ablation devices market during the forecast period due to high healthcare expenditure, incidence of cardiac disease and cancer, and the number of patients suffering from pain

  • Asia Pacific is expected to witness significant growth over the next decade due to increasing demand for minimally invasive procedures to treat cancer and growing awareness regarding the benefits of ablation method over the conventional surgical procedures

  • Some of the key players are Boston Scientific Corporation; Medtronic; Stryker; Cosman Medical, Inc.; St. Jude Medical; Smith & Nephew; Johnson & Johnson (J&J) Services, LLC; and AngioDynamics.

U.S. radiofrequency ablation devices market size, by product, 2015 - 2026 (USD Million)

Browse More Reports in Medical Devices:

Cochlear Implants Market: The cochlear implants market is anticipated to witness significant growth during the forecast period, which can be attributed to a favorable reimbursement scenario, rising awareness about hearing aids, and increasing adoption of implants.

Pen Needles Market: Rising prevalence of diabetes is the primary reason for the significant growth of pen needles market. According to the International Diabetes Federation (IDF), nearly 415 million people were suffering from diabetes in 2015.

According to the American Society of Plastic Surgeons, by the end of 2015, 15.9 million minimally invasive cosmetic surgeries were performed in U.S. According to the Centers for Disease Control and Prevention (CDC), more than six million laparoscopic procedures are performed across the U.S. and EU countries every year.

Radiofrequency ablation is now used early in the management of patients suffering from atrial tachycardia or atrial fibrillation or other kinds of coronary disease. This factor is anticipated to boost the market growth. According to the American College of Cardiology Foundation, coronary heart disease is the leading cause of deaths (43.8%) in U.S., followed by stroke (16.8%), heart failure (9.0%), high BP (9.4%), and other CVDs (17.9%). By 2035, the total cost of CVD is expected to reach USD 1.1 trillion and is projected to affect 45.1% (130 million) adults in U.S.

Radiofrequency ablation devices market share, by application, 2018 (%)

Radiofrequency ablation can also be used to reduce neck pain, low-back pain, arthritis, and pelvic and peripheral nerve pain. According to WebMD LLC., RFA has been proven to be effective in more than 70% of the patients experiencing pain. Pain relief from RFA can last from six to 12 months or even a year.

Grand View Research has segmented the global radiofrequency ablation devices market based on type and region:

Radiofrequency Ablation Devices Product Outlook (Revenue, USD Million, 2015 – 2026)

  • Disposable Equipment

  • Capital Equipment

  • Reusable Equipment

Radiofrequency Ablation Devices Mode of Delivery Outlook (Revenue, USD Million, 2015 – 2026)

  • Surgical Oncology

  • Cardiology & Cardiac Rhythm Management

  • Cosmetology

  • Gynecology

  • Pain Management

Radiofrequency Ablation Devices Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • France

    • Germany

    • Italy

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

Explore radiofrequency ablation devices market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market

Categories